Peptide receptor radionuclide therapy with 177Lu-DOTATATE: the IEO phase I-II study

Peptide receptor therapies in neuroendocrine tumors

(2014) L. Bodei et al.   JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION

Multidisciplinary Approach Including Receptor Radionuclide Therapy with90Y-Dotatoc ([90Y-Dota0, Tyr3]-Octreotide) and177Lu-Dotatate ([177Lu-Dota0, Tyr3]-Octreotate) in Ectopic Cushing Syndrome from a Metastatic Gastrinoma: A Promising Proposal

(2013) Maria Davì et al.   Endocrine Practice

Procedure guidelines for PET/CT tumour imaging with 68Ga-DOTA-conjugated peptides: 68Ga-DOTA-TOC, 68Ga-DOTA-NOC, 68Ga-DOTA-TATE

(2010) Irene Virgolini et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Peptide Receptor Radionuclide Therapy in a Case of Multiple Spinal Canal and Cranial Paragangliomas

(2010) Diego Cecchin et al.   JOURNAL OF CLINICAL ONCOLOGY

68Ga-DOTANOC PET/CT Clinical Impact in Patients with Neuroendocrine Tumors

(2010) V. Ambrosini et al.   JOURNAL OF NUCLEAR MEDICINE

Somatostatin receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors

(2009) Dik J Kwekkeboom et al.   ENDOCRINE-RELATED CANCER

Peptide receptor radionuclide therapy with 90Y-DOTATOC in recurrent meningioma

(2009) Mirco Bartolomei et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group

(2009) Anja Rinke et al.   JOURNAL OF CLINICAL ONCOLOGY

Long-term evaluation of renal toxicity after peptide receptor radionuclide therapy with 90Y-DOTATOC and 177Lu-DOTATATE: the role of associated risk factors

(2008) Lisa Bodei et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Treatment With the Radiolabeled Somatostatin Analog [177Lu-DOTA0,Tyr3]Octreotate: Toxicity, Efficacy, and Survival

(2008) Dik J. Kwekkeboom et al.   JOURNAL OF CLINICAL ONCOLOGY

MIRD Pamphlet No. 20: The Effect of Model Assumptions on Kidney Dosimetry and Response--Implications for Radionuclide Therapy

(2008) B. W. Wessels et al.   JOURNAL OF NUCLEAR MEDICINE

Gastroenteropancreatic neuroendocrine tumours

(2008) Irvin M Modlin et al.   LANCET ONCOLOGY